Success Story: EB-1A Approved After RFE! Our Firm Assisted a Pakistani Postdoctoral Researcher under Premium Processing
Client’s Testimonial:
"From the initial evaluation through the RFE response, the firm provided meticulous attention to detail and clear strategic direction at every stage of my EB-1A petition. Their ability to translate highly technical research achievements into a compelling and well-structured legal narrative was truly remarkable. I am especially grateful to Attorney A.V. for his dedicated work in preparing the initial petition, and to Attorney E.C. for crafting a strong and thoughtful RFE response that addressed every concern with precision and clarity. Their professionalism, responsiveness, and commitment to excellence were instrumental in the successful approval of my EB-1A petition. I sincerely appreciate their support throughout this journey.”
On February 25th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Researcher in the Field of Computational Pathology (Approval Notice).
General Field: Computational Pathology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: Pakistan
State of Residence at the Time of Filing: Texas
Approval Notice Date: February 25th, 2026
Processing Time: 3 months and 22 days (Premium Processing Requested)
Case Summary:
Our firm is pleased to share the successful approval of an EB-1A (Alien of Extraordinary Ability) petition for a postdoctoral researcher in the field of computational pathology, approved in over 3 months under premium processing. The client, who holds a Ph.D. in computer science from Pakistan, approached our firm seeking support in securing permanent residency through the EB-1A category.
After a thorough review of the expert's achievements and impact, we prepared a compelling petition that presented a strong case for extraordinary ability. While a Request for Evidence (RFE) was issued shortly after filing, our team promptly prepared a comprehensive response that highlighted not only the objective metrics of the client's academic success but also the real-world impact of their work on advancing AI-driven cancer diagnostics and precision medicine in the United States. This approval underscores the client's extraordinary influence in computational pathology, multiple-instance learning, and medical imaging AI.
Accomplishments and Expertise
The client has established a strong reputation as a leading expert in computational pathology, with particular expertise in multiple-instance learning (MIL), whole-slide pathology image analysis, lung CT imaging, deep learning, and AI-driven cancer detection.
In support of the EB-1A petition, we highlighted several objective achievements, including:
- 11 peer-reviewed journal articles (5 first-authored), 5 peer-reviewed conference articles (3 first-authored), 1 abstract, and 3 preprints (1 first-authored)
- 67 completed peer reviews
- A citation record placing the client in the top 1% most highly cited authors
- Competitive research funding from the National Institutes of Health (NIH), the Cancer Prevention & Research Institute of Texas, Rexanna's Foundation for Fighting Lung Cancer, Pakistan's Higher Education Commission, and the National Center in Big Data and Cloud Computing
To further support the petition, we obtained two independent advisory opinions from highly regarded professionals. One independent expert stated:
"Ensuring that [Client]’s work proceeds is thus not only important to the field, but to the United States as well."
EB-1A Approval and OutlookWe are honored to have represented the researcher in this successful EB-1A petition and look forward to seeing the continued contributions they will make to advancing AI-driven cancer detection, precision oncology, and computational pathology in the United States. It has been a privilege to support them throughout this journey, and we extend our sincere best wishes for their continued success in both their professional and personal pursuits.